| 1 |
SWERDLOW S H, CAMPO E, HARRIS N L, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. Revised 4th ed. Lyon: IARC Press, 2017.
|
| 2 |
LEE J H, LEE S H. A poor prognostic case of peripheral T-cell lymphoma in the base of tongue with chemotherapy followed by radiation therapy[J]. Springerplus, 2014, 3: 731.
|
| 3 |
NARLA S, ANNAPURNESWARI S, PARAMESWARAN A, et al. Peripheral T-cell lymphoma of tongue: report of a rare case and review of literature[J]. J Oral Maxillofac Pathol, 2016, 20(2): 332.
|
| 4 |
薛敏, 高冶, 段介君. 以舌部肿物为表现的外周型T细胞淋巴瘤1例[J]. 宁夏医科大学学报, 2017, 39(1): 115-116.
|
|
XUE M, GAO Y, DUAN J J. A case of peripheral T-cell lymphoma presenting as a tongue mass[J]. Journal of Ningxia Medical University, 2017, 39(1): 115-116.
|
| 5 |
DOS SANTOS H L R, ALVES C G B, ALMENDRA MATTOS R M, et al. Peripheral T-cell non-Hodgkin lymphoma manifesting as a primary lesion on the lip: a rare case report[J]. Spec Care Dentist, 2018, 38(6): 438-444.
|
| 6 |
REN X Y, CHENG Y, WU S F, et al. Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status[J]. Diagn Pathol, 2020, 15(1): 30.
|
| 7 |
ALMEIDA DE ARRUDA J A, DE CASTRO ABRANTES T, CUNHA J L S, et al. Mature T/NK-cell lymphomas of the oral and maxillofacial region: a multi-institutional collaborative study[J]. J Oral Pathol Med, 2021, 50(6): 548-557.
|
| 8 |
ASADI A A, MAHMOUDI H, MOFIDI A, et al. Peripheral T-cell lymphoma of the oral cavity: a case report[J]. Cancer Rep (Hoboken), 2023, 6(1): e1751.
|
| 9 |
DE OLIVEIRA E M, DE CÁCERES C V B L, FERNANDES-RODRIGUES C I, et al. Oral manifestations of peripheral T cell lymphoma, not otherwise specified: case series and review of the current literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2025, 139(2): e37-e45.
|
| 10 |
PILERI S A, TABANELLI V, FIORI S, et al. Peripheral T-cell lymphoma, not otherwise specified: clinical manifestations, diagnosis, and future treatment[J]. Cancers (Basel), 2021, 13(18): 4535.
|
| 11 |
COSTELLO R, SANCHEZ C, LE TREUT T, et al. Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations[J]. Br J Haematol, 2010, 150(1): 21-27.
|
| 12 |
LUO J J, CRAVER A, BAHL K, et al. Etiology of non-Hodgkin lymphoma: a review from epidemiologic studies[J]. J Natl Cancer Cent, 2022, 2(4): 226-234.
|
| 13 |
COCCO P, VERMEULEN R, FLORE V, et al. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph analysis[J]. Occup Environ Med, 2013, 70(11): 795-802.
|
| 14 |
BASSIG B A, SHU X O, FRIESEN M C, et al. Occupational exposure to benzene and risk of non-Hodgkin lymphoma in an extended follow-up of two population-based prospective cohorts of Chinese men and women[J]. Int J Cancer, 2024, 155(12): 2159-2168.
|
| 15 |
BRYER E, HENRY D. Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literature[J]. Int J Hematol Oncol, 2018, 7(1): IJH03.
|
| 16 |
SCHMITZ N, DE LEVAL L. How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future[J]. Br J Haematol, 2017, 176(6): 851-866.
|
| 17 |
WENT P, AGOSTINELLI C, GALLAMINI A, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score[J]. J Clin Oncol, 2006, 24(16): 2472-2479.
|
| 18 |
LIM S T, HEE S W, QUEK R, et al. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis[J]. Eur J Haematol, 2008, 80(1): 55-60.
|
| 19 |
D′AMORE F, GAULARD P, TRÜMPER L, et al. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2015, 26(Suppl 5): v108-v115.
|
| 20 |
SHEN Q D, WANG L, ZHU H Y, et al. Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma[J]. J Cancer, 2021, 12(1): 163-169.
|
| 21 |
MINA A, PRO B. T time: emerging and new therapies for peripheral T-cell lymphoma[J]. Blood Rev, 2022, 52: 100889.
|
| 22 |
李静, 李志铭. 外周T细胞淋巴瘤和结外NK/T细胞淋巴瘤研究进展[J]. 肿瘤药学, 2024, 14(1): 16-21.
|
|
LI J, LI Z M. Research progress of peripheral T-cell lymphoma and extranodal NK/T-cell lymphoma [J]. Anti-tumor Pharmacy, 2024, 14(1): 16-21.
|